SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma
Aurobindo Pharma
BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 28, 16:00
754.75
10.85 (1.46%)
VOLUME 244,935
LIVE
NSE
Aug 28, 16:01
756.40
11.05 (1.48%)
VOLUME 3,666,904
News on Aurobindo Pharma
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Aurobindo Pharma: Outcome of AGM

2.46 pm | 28 Aug 2015 |  Source: Moneycontrol.com

Aurobindo Pharma Ltd has informed BSE that the Annual General Meeting (AGM) of the Company was held on August 27, 2015...

Top buzzing midcap stocks to trade on August 28 

1.26 pm | 28 Aug 2015 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Axis Bank, Bharti Airtel, Aurobindo Pharma, Jubilant L...

Aurobindo Pharma up 5%; Citi says top pick, sees 50% rally

10.52 am | 28 Aug 2015 |  Source: Moneycontrol.com

The brokerage expects Entecavir to be a potentially chunky and sustainable product for Aurobindo. It is only the third generic company (after Teva & P...

Aurobindo gets USFDA nod for hepatitis B drug

1.39 pm | 27 Aug 2015 |  Source: PTI

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Entecavir tablets in strengths of 0...

Aurobindo up 4%; USFDA nod to make, market hepatitis B drug

1.28 pm | 27 Aug 2015 |  Source: Moneycontrol.com

"The company has received the final approval from the USFDA to manufacture and market Entecavir Tablets, 0.5mg and 1mg," it said in a filing to the ex...

Aurobindo Pharma receives USFDA approval for entecavir tablets

1.12 pm | 27 Aug 2015 |  Source: Moneycontrol.com

Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Entecavir Tablets, 0.5mg and...

Buy Divis Lab, Wockhardt; add Aurobindo Pharma: Sukhani 

10.25 am | 27 Aug 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Divis Laboratories and Wockhardt and adding Aurobindo Pharma....

Invest in Infosys, SBI, Maruti, Sun Pharma, L&T: Sukhani 

11.18 am | 24 Aug 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can consider investing in Infosys, State Bank of India, ICICI Bank, Sun Pharmaceutical In...

Buy Cipla, Aurobindo Pharma: CA Rudramurthy 

3.47 pm | 21 Aug 2015 |  Source: CNBC-TV18

CA Rudramurthy of Vachana Investments is of the view that one can buy Cipla and Aurobindo Pharma....

Why pharma stocks may take a breather after recent run-up 

4.10 pm | 20 Aug 2015 |  Source: CNBC-TV18

In an interview with CNBC-TV18's Anuj Singhal and Ekta Batra, Surajit Pal, Pharma Analyst, Prabhudas Lilladher, discussed recent developments in the p...

Aurobindo Pharma gets USFDA nod to market ulcer drug

3.24 pm | 20 Aug 2015 |  Source: PTI

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Omeprazole delayed-release capsules...

Aurobindo Pharma receives USFDA approval for Omeprazole delayed-release capsules

1.18 pm | 20 Aug 2015 |  Source: Moneycontrol.com

Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Omeprazole Delayed-release C...

Aurobindo Pharma receives USFDA approval for Ibandronate sodium injection

1.17 pm | 20 Aug 2015 |  Source: Moneycontrol.com

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Ibandronate Sodium Injection, 3...

Aurobindo Pharma top pick, says Phani Sekhar 

4.29 pm | 19 Aug 2015 |  Source: CNBC-TV18

P Phani Sekhar of Karvy Stock Broking is of the view that Aurobindo Pharma is the top pick from the pharma space....

Accumulate Aurobindo Pharma; target of Rs 824: Angel

3.59 pm | 19 Aug 2015 |  Source: Moneycontrol.com

Angel Broking is bullish on Aurobindo Pharma and has recommended accumulate rating on the stock with a target of Rs 824 in its research report dated A...

Sun Pharma up 5%; BoAML upgrades to buy, weak rupee to aid

2.05 pm | 19 Aug 2015 |  Source: Moneycontrol.com

BoAML is betting big on Indian pharma companies as weak rupee is positive for the sector. It says Cadila, Aurobindo and Lupin are the biggest benefici...

Buy Aurobindo Pharma; target of Rs 845: Emkay

12.34 pm | 19 Aug 2015 |  Source: Moneycontrol.com

Brokerage house Emkay Global Financial Services is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 8...

Buy Aurobindo Pharma, UPL: Meghana Malkan 

3.18 pm | 17 Aug 2015 |  Source: CNBC-TV18

Meghana Malkan of malkansview.com recommends buying Aurobindo Pharma and UPL....

Look at IT, healthcare space: Jonathan Schiessel 

11.56 am | 15 Aug 2015 |  Source: CNBC-TV18

Jonathan Schiessel of Asburton is of the view that one may look at IT and healthcare space....

Positive on pharma, like Aurobindo Pharma: Dipan Mehta 

4.52 pm | 13 Aug 2015 |  Source: CNBC-TV18

Dipan Mehta, Member at BSE & NSE is extremely positive on the pharma industry but feels that Sun Pharma will underperform....

1 2 3 4 5 6
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.